Nitric oxide in liver diseases: Friend, foe, or just passerby?

Annals of the New York Academy of Sciences

Volumn 962, Issue , 2002, Pages 275-295

  Hon, Wei Min ^a,b   Lee, Kang Hoe ^a   Khoo, Hoon Eng ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Friend or foe; Liver diseases; Nitric oxide

Indexed keywords

NITRIC OXIDE;

APOPTOSIS; CONFERENCE PAPER; CYTOTOXICITY; ENZYME ACTIVITY; HUMAN; LIVER DISEASE; NONHUMAN; PATHOPHYSIOLOGY; THROMBOCYTE AGGREGATION INHIBITION;

EID: 0036268227     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2002.tb04074.x     Document Type: Conference Paper

References (157)

1. Nitric oxide: Physiology, pathophysiology, and pharmacology
2. The nitric oxide and cGMP signal transduction system: Regulation and mechanism of action
3. Nitric oxide as a secretory product of mammalian cells
4. Peroxynitrite: Mediator of the toxic action of nitric oxide
5. Clinical biology of nitric oxide
6. The L-arginine-nitric oxide pathway
7. Nitric oxide modulates hepatic vascular tone in normal rat liver
8. Nitric oxide synthase expression is induced in hepatocytes in vivo during hepatic inflammation
9. Differential induction of nitric oxide synthase in hepatocytes during endotoxemia and the acute-phase response
10. Prostanoids inhibit Kupffer cell nitric oxide synthesis
11. Regulation of inducible nitric oxide synthase in hepatic sinusoidal endothelial cells
12. Induction of hepatic Ito cell nitric oxide production after acute endotoxemia
13. Interleukin 1β markedly stimulates nitric oxide formation in the absence of other cytokines or lipopolysaccharide in primary cultured rat hepatocytes but not in Kupffer cells
14. Cell death at the millennium. Implications for liver diseases
15. Nitric oxide synthesis serves to reduce hepatic damage during acute murine endotoxemia
16. Liver perfusion and hepatocellular inflammatory response in sepsis
17. Differential effects of nitric oxide synthase inhibitors on endotoxin-induced liver damage in rats
18. Inhibition of nitric oxide synthesis during endotoxemia promotes intrahepatic thrombosis and an oxygen radical-mediated hepatic injury
19. Inhibition of nitric oxide synthase during hemorrhagic shock increases hepatic injury
20. Nitric oxide synthase inhibitor increases hepatic injury with formation of oxidative DNA damage and microcirculatory disturbance in endotoxemic rats
21. 4-induced acute liver injury of mice
22. Nitric oxide protects cultured rat hepatocytes from tumor necrosis factor-alpha-induced apoptosis by inducing heat shock protein 70 expression
23. Targeting nitric oxide (NO) delivery in vivo. Design of a liver-selective NO donor prodrug that blocks tumor necrosis factor-alpha-induced apoptosis and toxicity in the liver
24. Nitric oxide-mediated apoptosis in murine peritoneal macrophages
25. Nitric oxide induces apoptosis in mouse thymocytes
26. A role for nitric oxide and other inflammatory mediators in cytokine-induced pancreatic beta-cell dysfunction and destruction
27. The anti-apoptotic actions of nitric oxide in hepatocytes
28. Interleukin-1 and nitric oxide protect against tumor necrosis factor alpha-induced liver injury through distinct pathways
29. Differential effects of nonselective nitric oxide synthase (NOS) and selective inducible NOS inhibition on hepatic necrosis, apoptosis, ICAM-1 expression, and neutrophil accumulation during endotoxemia
30. Nitric oxide inhibits apoptosis by preventing increases in caspase-3-like activity via two distinct mechanisms
31. Nitric oxide delays the death of trophic factor-deprived PC12 cells and sympathetic neurons by a cGMP-mediated mechanism
32. Protection by nitric oxide against liver inflammatory injury in animals carrying a nitric oxide synthase-2 transgene
33. Distinct roles of tumor necrosis factor-alpha and nitric oxide in acute liver injury induced by carbon tetrachloride in mice
34. Cocaine-induced liver injury in mice is mediated by nitric oxide and reactive oxygen species
35. Influence of aminoguanidine on parameters of liver injury and regeneration induced in rats by a necrogenic dose of thioacetamide
36. Role of nitric oxide in acetaminophen-induced hepatotoxicity in the rat
37. Inducible nitric oxide synthase is critical for immune-mediated liver injury in mice
38. The antiviral role of nitric oxide
39. The antiviral effects of nitric oxide
40. Evidence for antiviral effect of nitric oxide. Inhibition of herpes simplex virus type 1 replication
41. Nitric oxide inhibits viral replication in murine myocarditis
42. Inhibition of Japanese encephalitis virus infection by nitric oxide: Antiviral effect of nitric oxide on RNA virus replication
43. Effects of immunosuppressive therapy on viral markers in chronic active hepatitis B
44. Nitric oxide inhibits hepativis B virus replication in the livers of transgenic mice
45. Elevated formation of nitrate and N-nitrosodimethylamine in woodchucks (Marmota monax) associated with chronic woodchuck hepatitis virus infection
46. Nitrite and nitrosamine synthesis by hepatocytes isolated from normal woodchucks (Marmota monax) and woodchucks chronically infected with woodchuck hepatitis virus
47. Woodchuck hepatitis virus surface antigen induces nitric oxide synthesis in hepatocytes: Possible role in hepatocarcinogenesis
48. Hepatic expression of inducible nitric oxide synthase transcripts in chronic hepatitis C virus infection: Relation to hepatic viral load and liver injury
49. Decreased nitric oxide production in chronic viral hepatitis B and C
50. High plasma concentrations of nitrite/nitrate in patients with hepatocellular carcinoma
51. Plasma nitrites/nitrates in HCV infection and hepatocellular carcinoma
52. Inducible nitric oxide synthase expression in chronic viral hepatitis. Evidence for a virus-induced gene upregulation
53. Liver infiltrating T lymphocytes express interferon gamma and inducible nitric oxide synthase in chronic hepatitis C virus infection
54. Intrahepatic accumulation of nitrotyrosine in chronic viral hepatitis is associated with histological severity of liver disease
55. Hepatitis B virus X protein transactivates the inducible nitric oxide synthase promoter
56. The chemistry of DNA damage from nitric oxide and peroxynitrite
57. Hepatitis B virus X protein protects against anti-Fas-mediated apoptosis in human liver cells by inducing NF-κ B
58. Hyperdynamic circulation in cirrhosis: A role for nitric oxide?
59. Induction of nitric oxide synthase by cytokines in vascular smooth muscle cells
60. Dexamethasone prevents the induction by endotoxin of a nitric oxide synthase and the associated effects on vascular tone: An insight into endotoxin shock
61. The acute splanchnic and peripheral tissue metabolic response to endotoxin in humans
62. The cardiovascular response of normal humans to the administration of endotoxin
63. Effects of a nitric oxide synthase inhibitor in humans with septic shock
64. Endotoxin levels measured by a chromogenic assay in portal, hepatic and peripheral venous blood in patients with cirrhosis
65. A simple turbidimetric time assay of the endotoxin in plasma
66. Role of nitric oxide in the in vitro splanchnic vascular hyporeactivity in ascitic cirrhotic rats
67. Modulation of the hyperdynamic circulation of cirrhotic rats by nitric oxide inhibition
68. Increased nitric oxide-dependent vasorelaxation in aortic rings of cirrhotic rats with ascites
69. Atrial natriuretic peptide in liver cirrhosis with mild ascites
70. Nitric oxide in liver failure
71. Increased serum nitrite and nitrate levels in patients with cirrhosis: Relationship to endotoxemia
72. Endogenous nitric oxide production is augmented as the severity advances in patients with liver cirrhosis
73. Long-lasting NO overproduction in cirrhotic patients with spontaneous bacterial peritonitis
74. Serum and ascitic fluid nitrate levels in patients with cirrhosis
75. Hyperdynamic circulation in patients with cirrhosis: Direct measurement of nitric oxide levels in hepatic and portal veins
76. Increased nitric oxide in the exhaled air of patients with decompensated liver cirrhosis
77. Increased production of nitric oxide by neutrophils and monocytes from cirrhotic patients with ascites and hyperdynamic circulation
78. Nitric oxide synthase activity is increased in relation to the severity of liver dysfunction
79. Smooth muscle-derived nitric oxide is elevated in isolated forearm veins in human alcoholic cirrhosis
80. Inhibition of nitric oxide synthesis in the forearm arterial bed of patients with advanced cirrhosis
81. Evidence against a role for inducible nitric oxide synthase in the hyperdynamic circulation of portalhypertensive rats
82. Vascular nitric oxide production during the development of two experimental models of portal hypertension
83. Serum and urinary nitrate levels in liver cirrhosis: Endotoxemia, renal function and hyperdynamic circulation
84. Metabolism and excretion of nitric oxide in humans. An experimental and clinical study
85. Reduced nitric oxide production by endothelial cells in cirrhotic rat liver: Endothelial dysfunction in portal hypertension
86. Hepatic and splanchnic nitric oxide activity in patients with cirrhosis
87. Hepatocellular carcinoma
88. Increased nitrosamine and nitrate biosynthesis mediated by nitric oxide synthase induced in hamsters infected with liver fluke (Opisthorchis viverrini)
89. Chronic hepatitis C virus infection in humans: Induction of hepatic nitric oxide synthase and proposed mechanisms for carcinogenesis
90. Chronic infections and inflammatory processes as cancer risk factors: Possible role of nitric oxide in carcinogenesis
91. Plasma nitrite/nitrate concentrations as a tumor marker for hepatocellular carcinoma
92. The multifaceted roles of nitric oxide in cancer
93. DNA damage and mutation in human cells exposed to nitric oxide in vitro
94. DNA deaminating ability and genotoxicity of nitric oxide and its progenitors
95. Nitric oxide: A cytotoxic activated macrophage effector molecule
96. Role of nitric oxide in genotoxicity: Implication for carcinogenesis
97. Precore mutations and core clustering mutations in chronic hepatitis B virus infection
98. p53 mutations in human cancers
99. Mutations of the tumour suppressor gene p53 in colorectal and hepatocellular carcinomas
100. The p53 tumour suppressor gene
101. Nitric oxide induces conformational and functional modifications of wild-type p53 tumor suppressor protein
102. Nitric oxide-induced p53 accumulation and regulation of inducible nitric oxide synthase expression by wild-type p53
103. Nitric oxide mediates mitogenic effect of VEGF on coronary venular endothelium
104. Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis
105. Induction of vascular endothelial growth factor by nitric oxide in human glioblastoma and hepatocellular carcinoma cells
106. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract
107. Increased expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in kidney and bladder carcinomas
108. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancer
109. Clinical significance of vascular endothelial growth factor and basic fibroblast growth factor gene expression in liver tumor
110. Expression of vascular permeability factor/vascular endothelial growth factor in human hepatocellular carcinoma
111. Rat Kupffer cell-derived nitric oxide suppresses proliferation and induces apoptosis of syngeneic hepatoma cells
112. Kupffer cell-mediated cytotoxicity against hepatoma cells occurs through production of nitric oxide and adhesion via ICAM-1/CD18
113. Role in nitric oxide in Kupffer cell-mediated hepatoma cell cytotoxicity in vitro and ex vivo
114. Nitric oxide generation. A predictive parameter of acute allograft rejection
115. Increased urinary nitrate excretion associated with hepatic allograft rejection in experimental rat models and clinical cases
116. Nitric oxide production in hepatic cell rejection of liver transplant patients
117. Simultaneous evaluation of nitric oxide synthesis and tissue oxygenation in rat liver allograft rejection using near-infrared spectroscopy
118. Cellular localization and effect of nitric oxide synthesis in a rat model of orthotopic liver transplantation
119. Kinetics and significance of graft tissue nitric oxide after rat and mouse liver transplantation
120. Intrahepatic expression of inducible nitric oxide synthase in acute liver allograft rejection: Evidence of modulation by corticosteroids
121. Nitric oxide synthesis in the in vivo allograft response: A possible regulatory mechanism
122. Nitric oxide decreases oxidant-mediated hepatocyte injury
123. The effect of nitric oxide on ischemia-reperfusion injury in rat liver
124. Inhibition of nitric oxide synthesis in ischemia/reperfusion of the rat liver is followed by impairment of hepatic microvascular blood flow
125. Role of nitric oxide and superoxide in acute cardiac allograft rejection in rats
126. NOX 100, a nitric oxide scavenger, enhances cardiac allograft survival and promotes long-term graft acceptance
127. Superoxide enhances interleukin 1β-mediated transcription of the hepatocyte-inducible nitric oxide synthase gene
128. Liver sinusoidal endothelial cells are responsible for nitric oxide modulation of resistance in the hepatic sinusoids
129. Inhibition of nitric oxide synthesis aggravates reperfusion injury after hepatic ischemia and endotoxemia
130. Hepatoprotective effect of endogenous nitric oxide during ischemia-reperfusion in the rat
131. Role of endogenous nitric oxide in ischemia-reperfusion injury in rat liver
132. Beneficial effects of FK409, a novel nitric oxide donor, on reperfusion injury of rat liver
133. Protective role of nitric oxide in ischemia and reperfusion injury of the liver
134. V-PYRRO/NO: An hepatoselective nitric oxide donor improves porcine liver hemodynamics and function after ischemia reperfusion
135. Role of endothelins and nitric oxide in hepatic reperfusion injury in the rat
136. NO modulates P-selectin and ICAM-1 mRNA expression and hemodynamic alterations in hepatic I/R
137. Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines
138. Endotoxin-stimulated nitric oxide production increases injury and reduces rat liver chemiluminescence during reperfusion
139. Beneficial effects of inducible nitric oxide synthase inhibitor on reperfusion injury in the pig liver
140. Functional requirement of the hypoxia-responsive element in the activation of the inducible nitric oxide synthase promoter by the iron chelator desferrioxamine
141. Liver-type arginase in serum during and after liver transplantation: A novel index in monitoring conditions of the liver graft and its clinical significance
142. Arginase release following liver reperfusion. Evidence of hemodynamic action of arginase infusions
143. Endothelin-1 is involved in the pathogenesis of ischemia/reperfusion liver injury by hepatic microcirculatory disturbances
144. Modulation of endothelin and nitric oxide: A rational approach to improve canine hepatic microcirculation
145. Initiation of liver growth by tumor necrosis factor: Deficient liver regeneration in mice lacking type I tumor necrosis factor receptor
146. Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice
147. Rapid activation of post-hepatectomy factor/nuclear factor kappa B in hepatocytes, a primary response in the regenerating liver
148. Rapid activation of the Stat3 transcription complex in liver regeneration
149. Liver regeneration
150. Epr evidence of nitric oxide production by the regenerating rat liver
151. Nitric oxide is released in regenerating liver after partial hepatectomy
152. Nitric oxide release and enhancement of lipid peroxidation in regenerating rat liver
153. Nitric oxide production by cells isolated from regenerating rat liver
154. Cytokines, nitric oxide synthesis and liver regeneration
155. Nuclear factor κB is required for the transcriptional control of type II NO synthase in regenerating liver
156. Evidence of nitric oxide, a flow-dependent factor, being a trigger of liver regeneration in rats
157. Impaired liver regeneration in inducible nitric oxide synthase deficient mice